PMV PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $359.1M | $361.4M |
| FY2021 | — | $308.6M | $172.5M |
| FY2022 | — | $246.0M | $108.3M |
| FY2023 | — | $225.7M | $37.7M |
| FY2024 | — | $176.1M | $40.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $359.1M | $361.4M |
| FY2021 | — | $308.6M | $172.5M |
| FY2022 | — | $246.0M | $108.3M |
| FY2023 | — | $225.7M | $37.7M |
| FY2024 | — | $176.1M | $40.9M |